Protective role of HLA-B27 in HIV and hepatitis C virus infection;Protektiver Effekt von HLA-B27 auf den Verlauf der HIV- und Hepatitis-C-Virus-Infektion

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 7, 2011, Pages 320-324

  Neumann Haefelin, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ancylosing spondylitis; hepatitis C virus; HLA B27; human immunodeficiency virus; viral escape

Indexed keywords

HLA B27 ANTIGEN;

CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; VIRAL CLEARANCE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; ARTHRITIS, REACTIVE; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; GENETIC LOCI; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HLA-B27 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; SPONDYLITIS, ANKYLOSING; UVEITIS, ANTERIOR; VIRAL LOAD;

EID: 79951483790     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1272531     Document Type: Review

References (14)

1. Brewerton D A., Hart F D., Nicholls A et al. Ankylosing spondylitis and HL-A 27. Lancet 1973 1 904-907
2. Chessman D, Kostenko L, Lethborg T et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug (Pubitemid 351784513)
3. Dazert E, Neumann-Haefelin C, Bressanelli S et al. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J Clin Invest 2009 119 376-386
4. Goulder P J., Phillips R E., Colbert R A. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997 3 212-217 (Pubitemid 27064707)
5. Goulder P J., Watkins D I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008 8 619-630
6. Kaslow R A., Carrington M, Apple R et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996 2 405-411 (Pubitemid 26193012)
7. Lopez de Castro J A. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007 108 27-33
8. Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002 359 727-732 (Pubitemid 34215071)
9. McKiernan S M., Hagan R, Curry M et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004 40 108-114 (Pubitemid 38877575)
10. McMichael A J. Triple bypass: complicated paths to HIV escape. J Exp Med 2007 204 2785-2788
11. Neumann-Haefelin C, McKiernan S, Ward S et al. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 2006 43 563-572
12. Neumann-Haefelin C, Timm J, Schmidt J et al. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology 2010 51 54-62
13. Nixon D F., Townsend A R., Elvin J G. et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988 336 484-487
14. Schneidewind A, Brockman M A., Sidney J et al. Structural and functional constraints limit options for CTL escape in the Immunodominant HLA-B27 restricted epitope in HIV-1 capsid. J Virol 2008 82 5594-5605 (Pubitemid 351705266)